胆甾烯基豆蔻酸酯
胆甾烯基豆蔻酸酯 性质
| 熔点 | 84 °C |
|---|---|
| 沸点 | 589.77°C (rough estimate) |
| 密度 | 0.9309 (rough estimate) |
| 折射率 | 1.5250 (estimate) |
| 储存条件 | Sealed in dry,2-8°C |
| 溶解度 | 氯仿（微溶）、己烷（微溶） |
| 形态 | 结晶固体 |
| LogP | 16.656 (est) |
| CAS 数据库 | 1989-52-2(CAS DataBase Reference) |
| NIST化学物质信息 | Cholesteryl myristate(1989-52-2) |
| EPA化学物质信息 | Cholest-5-en-3-ol (3.beta.)-, tetradecanoate (1989-52-2) |
胆甾烯基豆蔻酸酯 用途与合成方法
|
Human Endogenous Metabolite
|
Mesenchymal stem cells (MSCs) transfected by the Id1 promoter reporter construct, cholesterol myristate increases the activity of Id1 promoter. Cholesterol myristate inhibits the apoptosis of MSCs induced by serum-free. Cholesterol myristate increases the expression of Id1 and its target gene bcl-x/l in MSCs treated with serum-free. Moreover, noggin, a BMP antagonist, reduces the anti-apoptotic effects of cholesterol myristate. Cholesterol myristate inhibits the apoptosis of PC12 cells induced in serum-free condition. Cholesterol myristate significantly increases the expression of BMP4, BMPRIA, p-Smad1/5/8, Id1 and its antiapoptotic target gene Bcl-xL in PC12 cells treated in serum-free condition.
胆甾烯基豆蔻酸酯 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2024-01-25 | HY-N2338 | 胆甾烯基豆蔻酸酯 | 1989-52-2 | 250mg | 600 |
| 2024-01-16 | C0675 | 豆蔻酸胆固醇酯 | 1989-52-2 | 10G | 320 |
